Instrumento Inactivo

Otros idiomas GENB AS Other OTC

Acciones

US3723032062

Tiempo real estimado Cboe BZX Otros sitios de cotización 20:32:55 21/05/2024			Varia. Cinco días.	Varia. 1 de enero.
29,3 ^USD	+61,52 %		+0,50 %	+10,11 %

15/05	El consejero delegado de Genmab afirma que las empresas occidentales deberían aprovechar la "impresionante innovación" de China	MT
15/05	Bolt Biotherapeutics detiene el desarrollo del trastuzumab imbotolimod y reduce su plantilla en un 50	MT

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Genmab Completes Acquisition of ProfoundBio	17:11
Genmab Completes Acquisition of ProfoundBio	17:06
Transactions in Connection with Share Buy-back Program	13:20
Legal Limbo: Genmab's Ofatumumab SPC Dilemma Heads To CJEU	20/05
Genmab CEO Says Western Firms Should Tap Into China's 'Impressive Innovation'	15/05
Bolt Biotherapeutics Stops Development of Trastuzumab Imbotolimod, Cuts Workforce by 50%	15/05
Genmab to Present New and Updated Results From Multiple Clinical Trials Evaluating Epcoritamab Across Various B-Cell Malignancies at the 2024 European Hematology Association (EHA) Congress	14/05
Genmab A/S to Present New and Updated Results from Multiple Clinical Trials Evaluating Epcoritamab Across Various B-Cell Malignancies At the 2024 European Hematology Association Congress	14/05
Genmab to Present New and Updated Results From Multiple Clinical Trials Evaluating Epcoritamab Across Various B-Cell Malignancies at the 2024 European Hematology Association (EHA) Congress	14/05
Transactions in Connection with Share Buy-back Program	13/05
Genmab A/S : has published its Articles of Association	08/05
Genmab A/S : Articles of association dated May 07, 2024 – English	08/05
Capital Increase in Genmab as a Result of Employee Warrant Exercise	07/05
OPINIONI DEGLI ANALISTI DEL GIORNO : Italgas, Amplifon, Enel, BBVA, Aperam, Safran, Santander, Pandora, Amadeus It, Lonza, ASM International...	07/05
AVIS D'ANALYSTES DU JOUR : Thales, Safran, Schneider, Ubisoft, Pandora, Lonza, ASM International...	07/05
Transactions in Connection with Share Buy-back Program	06/05
OPINIONI DEGLI ANALISTI DEL GIORNO : ACS, Safran, Santander, Endesa, Amadeus It, Telefónica, Aena, Cellnex, Sixt, JCDecaux...	06/05
AVIS D'ANALYSTES DU JOUR : Crédit Agricole, Safran, Société Générale, Vinci, Air France, Cellnex, JCDecaux...	06/05
GENMAB : A good start to 2024; guidance unchanged	03/05
Aggiornamento sui forti movimenti della giornata: Banks, Genmab, Daimler Truck ... risultati riassunti qui!	03/05

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Titulares

GENMAB : Un buen comienzo para 2024; orientación sin cambios

03 de mayo 2024 a las 19:08

Genmab A/S: El otro éxito sanitario danés

13 de junio 2023 a las 16:17